Shares of DouYu International Holdings Limited DOYU rose sharply during Thursday’s session after announcing a share repurchase program.
DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024.
DouYu International shares jumped 14.2% to $0.8320 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Nova LifeStyle, Inc. NVFY shares jumped 204% to $4.71.
- Cingulate Inc. CING climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD).
- Bone Biologics Corporation BBLG gained 62.2% to $7.54.
- SenesTech, Inc. SNES shares climbed 50.7% to $1.30. HC Wainwright & Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4.
- Microbot Medical Inc. MBOT rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study.
- Sidus Space, Inc. SIDU gained 32% to $5.81.
- DatChat, Inc. DATS rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators.
- SEALSQ Corp LAES gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure cryptocurrency transactions against the looming threat of quantum computing.
- Ocean Biomedical, Inc. OCEA surged 21.4% to $0.7299.
- DSS, Inc. DSS jumped 21% to $0.1477.
- RenovoRx, Inc. RNXT gained 20% to $1.2599.
- Arcutis Biotherapeutics, Inc. ARQT rose 20% to $3.6250. The FDA recently approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
- Envoy Medical, Inc. COCH gained 17.1% to $1.98.
- Flux Power Holdings, Inc. FLUX rose 16.6% to $4.00.
- Next.e.GO N.V. EGOX shares rose 14.5% to $0.5321 after gaining 6% on Wednesday.
- Iovance Biotherapeutics, Inc. IOVA gained 14.2% to $8.26. Iovance Biotherapeutics announced a clinical program update for LN-145 TIL therapy in non-small lung cancer (NSCLC).
- Ampio Pharmaceuticals, Inc. AMPE shares gained 11.8% to $2.4611 after jumping 20% on Wednesday.
- Altice USA, Inc. ATUS rose 11.8% to $3.41 after gaining around 12% on Wednesday.
- Esperion Therapeutics, Inc. ESPR jumped 11.4% to $3.1550.
- Altice USA, Inc. ATUS gained 10.1% to $3.36.
- Lufax Holding Ltd LU jumped 9.3% to $3.05.
- UP Fintech Holding Limited TIGR gained 9.2% to $4.4980.
- TeraWulf Inc. WULF shares gained 8.2% to $3.1150 after gaining around 30% on Wednesday.
Losers
- Cytosorbents Corporation CTSO shares fell 40.2% to $0.9733. CytoSorbents released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the pivotal U.S. and Canadian STAR-T trial.
- Bluejay Diagnostics, Inc. BJDX fell 29.5% to $1.2691. Bluejay Diagnostics announced pricing of $3.5 million public offering of 2,692,308 shares at $1.30 per share.
- Velo3D, Inc. VLD fell 25.7% to $0.4683 after the company announced a registered direct offering.
- Meihua International Medical Technologies Co., Ltd. MHUA declined 23% to $2.0808. Meihua International Medical Technologies entered into securities purchase agreement with investors to issue and sell initial $6 million tranche in offering of $50.5 million of its securities.
- IMAC Holdings, Inc. BACK dipped 21.4% to $2.1206.
- Sentage Holdings Inc. SNTG fell 21% to $1.58. Sentage Holdings recently reported a loss of 46 cents per share in the six months ended June 30, 2023, versus a year-ago loss of 41 cents per share.
- Airship AI Holdings, Inc. AISP declined 17% to $2.14.
- NeoGenomics, Inc. NEO fell 16.4% to $17.13 after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics' RaDar test.
- Baosheng Media Group Holdings Limited BAOS fell 16.3% to $3.58.
- Linkage Global Inc LGCB declined 16.2% to $1.3357.
- Bit Brother Limited BETS fell 14.9% to $0.0114.
- RiskOn International, Inc. ROI fell 14.8% to $0.3661. Ault Alliance disclosed that its majority beneficially owned subsidiary, RiskOn International, expects to announce its new generative artificial intelligence platform and launch a relationship with its principal technology partner on Jan. 3, 2024.
- First Wave BioPharma, Inc. FWBI fell 14.6% to $4.7199. First Wave BioPharma recently announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases.
- Hallmark Financial Services, Inc. HALL fell 13.7% to $1.0101 after dipping 25% on Wednesday. On Dec. 26, the company announced that it intends to voluntary delist from the Nasdaq.
- AEye, Inc. LIDR shares fell 12.4% to $2.32 after gaining 19% on Wednesday.
- Calliditas Therapeutics AB CALT declined 11.6% to $25.19. Calliditas Therapeutics recently announced FDA approval of TARPEYO.
- Wheels Up Experience Inc. UP fell 10.8% to $5.12.
- Hut 8 Corp. HUT fell 10.1% to $16.29.
- Iris Energy Limited IREN dipped 9.7% to $8.64. Iris Energy recently announced that its 10 EH/s expansion program is fully funded following the completion of the targeted equity raising program.
- MyMD Pharmaceuticals, Inc. MYMD shares fell 9.4% to $0.3031 after jumping over 40% on Wednesday.
- Cyclo Therapeutics, Inc. CYTH shares fell 8.6% to $1.4973. Cyclo Therapeutics announced the closing of merger with Applied Molecular Transport Inc.
- 1847 Holdings LLC EFSH fell 8.2% to $0.4773. 1847 Holdings said it will effect a 1-for-4 reverse split of its common shares that will become effective on Jan. 8, 2024.
- Bridgeline Digital, Inc. BLIN fell 5.3% to $0.8501 following the release of fourth-quarter results.
Now Read This: Amazon, Adobe And 2 Other Stocks Insiders Are Selling
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid Day MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in